Embolization of angiographically visible type i and II utero-ovarian anastomoses during uterine artery embolization for fibroid tumors: Impact on symptom recurrence and permanent amenorrhea

Gloria M M Salazar, T. Gregory Walker, Raymond F. Conway, Kalpana Yeddula, Stephan Wicky, Arthur C. Waltman, Sanjeeva P. Kalva

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose To compare the incidences of symptom recurrence and permanent amenorrhea following uterine artery embolization (UAE) for symptomatic fibroid tumors in patients with type I and II utero-ovarian anastomoses (UOAs) with versus without ovarian artery embolization (OAE). Materials and Methods A retrospective, institutional review board-approved study of 99 women who underwent UAE for symptomatic fibroid tumors from April 2005 to October 2010 was conducted to identify patients who had type I or II UOAs at the time of UAE. Based on the embolization technique, patients were categorized into standard (ie, UAE only), combined (ie, UAE and OAE), and control (patients without UOAs who underwent UAE) groups. Data collected included patient characteristics, procedural technique and findings, symptom recurrence, secondary interventions, and permanent amenorrhea. Statistical analysis was performed with the Fisher exact test, with significance reached at P <.05. Results Twenty patients (20.2%; mean age, 46.9 y ± 6.3) had type I (n = 3) or II (n = 17) UOAs. Thirteen (65%) underwent UAE only (standard group) and seven (35%) underwent UAE and OAE (combined group). There were no significant differences between groups in demographics or in the incidence of permanent amenorrhea after procedures (follow-up, 561 d ± 490). There was a significantly higher incidence of symptom recurrence in the standard group compared with the control group (P =.01), with no differences between combined and control groups (P = 1). Conclusions There were no statistical differences in permanent amenorrhea rates in the groups studied, with significantly higher symptom recurrence rates observed when OAE was not performed in the setting of UOA.

Original languageEnglish (US)
Pages (from-to)1347-1352
Number of pages6
JournalJournal of Vascular and Interventional Radiology
Volume24
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Uterine Artery Embolization
Amenorrhea
Leiomyoma
Recurrence
Arteries
Incidence
Control Groups
Research Ethics Committees
Demography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Embolization of angiographically visible type i and II utero-ovarian anastomoses during uterine artery embolization for fibroid tumors : Impact on symptom recurrence and permanent amenorrhea. / Salazar, Gloria M M; Gregory Walker, T.; Conway, Raymond F.; Yeddula, Kalpana; Wicky, Stephan; Waltman, Arthur C.; Kalva, Sanjeeva P.

In: Journal of Vascular and Interventional Radiology, Vol. 24, No. 9, 09.2013, p. 1347-1352.

Research output: Contribution to journalArticle

Salazar, Gloria M M ; Gregory Walker, T. ; Conway, Raymond F. ; Yeddula, Kalpana ; Wicky, Stephan ; Waltman, Arthur C. ; Kalva, Sanjeeva P. / Embolization of angiographically visible type i and II utero-ovarian anastomoses during uterine artery embolization for fibroid tumors : Impact on symptom recurrence and permanent amenorrhea. In: Journal of Vascular and Interventional Radiology. 2013 ; Vol. 24, No. 9. pp. 1347-1352.
@article{583dbd26e0cf423593f62d71592cead8,
title = "Embolization of angiographically visible type i and II utero-ovarian anastomoses during uterine artery embolization for fibroid tumors: Impact on symptom recurrence and permanent amenorrhea",
abstract = "Purpose To compare the incidences of symptom recurrence and permanent amenorrhea following uterine artery embolization (UAE) for symptomatic fibroid tumors in patients with type I and II utero-ovarian anastomoses (UOAs) with versus without ovarian artery embolization (OAE). Materials and Methods A retrospective, institutional review board-approved study of 99 women who underwent UAE for symptomatic fibroid tumors from April 2005 to October 2010 was conducted to identify patients who had type I or II UOAs at the time of UAE. Based on the embolization technique, patients were categorized into standard (ie, UAE only), combined (ie, UAE and OAE), and control (patients without UOAs who underwent UAE) groups. Data collected included patient characteristics, procedural technique and findings, symptom recurrence, secondary interventions, and permanent amenorrhea. Statistical analysis was performed with the Fisher exact test, with significance reached at P <.05. Results Twenty patients (20.2{\%}; mean age, 46.9 y ± 6.3) had type I (n = 3) or II (n = 17) UOAs. Thirteen (65{\%}) underwent UAE only (standard group) and seven (35{\%}) underwent UAE and OAE (combined group). There were no significant differences between groups in demographics or in the incidence of permanent amenorrhea after procedures (follow-up, 561 d ± 490). There was a significantly higher incidence of symptom recurrence in the standard group compared with the control group (P =.01), with no differences between combined and control groups (P = 1). Conclusions There were no statistical differences in permanent amenorrhea rates in the groups studied, with significantly higher symptom recurrence rates observed when OAE was not performed in the setting of UOA.",
author = "Salazar, {Gloria M M} and {Gregory Walker}, T. and Conway, {Raymond F.} and Kalpana Yeddula and Stephan Wicky and Waltman, {Arthur C.} and Kalva, {Sanjeeva P.}",
year = "2013",
month = "9",
doi = "10.1016/j.jvir.2013.05.043",
language = "English (US)",
volume = "24",
pages = "1347--1352",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Embolization of angiographically visible type i and II utero-ovarian anastomoses during uterine artery embolization for fibroid tumors

T2 - Impact on symptom recurrence and permanent amenorrhea

AU - Salazar, Gloria M M

AU - Gregory Walker, T.

AU - Conway, Raymond F.

AU - Yeddula, Kalpana

AU - Wicky, Stephan

AU - Waltman, Arthur C.

AU - Kalva, Sanjeeva P.

PY - 2013/9

Y1 - 2013/9

N2 - Purpose To compare the incidences of symptom recurrence and permanent amenorrhea following uterine artery embolization (UAE) for symptomatic fibroid tumors in patients with type I and II utero-ovarian anastomoses (UOAs) with versus without ovarian artery embolization (OAE). Materials and Methods A retrospective, institutional review board-approved study of 99 women who underwent UAE for symptomatic fibroid tumors from April 2005 to October 2010 was conducted to identify patients who had type I or II UOAs at the time of UAE. Based on the embolization technique, patients were categorized into standard (ie, UAE only), combined (ie, UAE and OAE), and control (patients without UOAs who underwent UAE) groups. Data collected included patient characteristics, procedural technique and findings, symptom recurrence, secondary interventions, and permanent amenorrhea. Statistical analysis was performed with the Fisher exact test, with significance reached at P <.05. Results Twenty patients (20.2%; mean age, 46.9 y ± 6.3) had type I (n = 3) or II (n = 17) UOAs. Thirteen (65%) underwent UAE only (standard group) and seven (35%) underwent UAE and OAE (combined group). There were no significant differences between groups in demographics or in the incidence of permanent amenorrhea after procedures (follow-up, 561 d ± 490). There was a significantly higher incidence of symptom recurrence in the standard group compared with the control group (P =.01), with no differences between combined and control groups (P = 1). Conclusions There were no statistical differences in permanent amenorrhea rates in the groups studied, with significantly higher symptom recurrence rates observed when OAE was not performed in the setting of UOA.

AB - Purpose To compare the incidences of symptom recurrence and permanent amenorrhea following uterine artery embolization (UAE) for symptomatic fibroid tumors in patients with type I and II utero-ovarian anastomoses (UOAs) with versus without ovarian artery embolization (OAE). Materials and Methods A retrospective, institutional review board-approved study of 99 women who underwent UAE for symptomatic fibroid tumors from April 2005 to October 2010 was conducted to identify patients who had type I or II UOAs at the time of UAE. Based on the embolization technique, patients were categorized into standard (ie, UAE only), combined (ie, UAE and OAE), and control (patients without UOAs who underwent UAE) groups. Data collected included patient characteristics, procedural technique and findings, symptom recurrence, secondary interventions, and permanent amenorrhea. Statistical analysis was performed with the Fisher exact test, with significance reached at P <.05. Results Twenty patients (20.2%; mean age, 46.9 y ± 6.3) had type I (n = 3) or II (n = 17) UOAs. Thirteen (65%) underwent UAE only (standard group) and seven (35%) underwent UAE and OAE (combined group). There were no significant differences between groups in demographics or in the incidence of permanent amenorrhea after procedures (follow-up, 561 d ± 490). There was a significantly higher incidence of symptom recurrence in the standard group compared with the control group (P =.01), with no differences between combined and control groups (P = 1). Conclusions There were no statistical differences in permanent amenorrhea rates in the groups studied, with significantly higher symptom recurrence rates observed when OAE was not performed in the setting of UOA.

UR - http://www.scopus.com/inward/record.url?scp=84883225892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883225892&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2013.05.043

DO - 10.1016/j.jvir.2013.05.043

M3 - Article

C2 - 23871695

AN - SCOPUS:84883225892

VL - 24

SP - 1347

EP - 1352

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 9

ER -